SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bittoo Kanwar, MD
Applied Molecular Transport
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Llc Arensia Exploratory Medicine
Tbilisi, Georgia
- Charité Research Organisation Gmbh
Berlin, Germany
- Ics Arensia Exploratory Medicine Srl
Chisinau, Moldova
- Medical Center of Harmoniya Krasy, Department of Clinical Trials
Kyiv, Ukraine
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2019
- Primary completion
- 30 Apr 2020
- Completion
- 30 Apr 2020
- Last update posted
- 28 Oct 2020
- Registered enrollment
- 52
- Registry id
- NCT04224857
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.